Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ahnfelt-Rønne

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Klinische Wochenschrift|December 15, 1991
Involvement of oxygen-derived free radicals in the pathogenesis of chronic inflammatory bowel diseaseO H Nielsen, I Ahnfelt-Rønne
Agents and Actions|June 1, 1987
The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavengerI Ahnfelt-Rønne, O H Nielsen
Agents and Actions|January 1, 1990
The leukotriene D4/E4 antagonist SR2640: recent results with smooth muscle preparationsD Kirstein, S Rachlin, I Ahnfelt-Rønne
European Journal of Pharmacology|October 11, 1988
A novel leukotriene D4/E4 antagonist, SR2640 (2-[3-(2-quinolylmethoxy)phenylamino]benzoic acid)I Ahnfelt-Rønne, D Kirstein, C Kaergaard-Nielsen
Agents and Actions|January 1, 1989
SR2640 (2-[3-(2-quinolylmethoxy)phenylamino]benzoic acid): a novel leukotriene antagonistI Ahnfelt-Rønne, D Kirstein, C Kaergaard-Nielsen
Agents and Actions|December 1, 1981
Chronic inflammation in adjuvant arthritic rats correlates with enhancement of 12-L-HETE-synthesisI Ahnfelt-Rønne, E Bramm, E Arrigoni-Martelli
Gut|February 1, 1987
Abnormal metabolism of arachidonic acid in chronic inflammatory bowel disease: enhanced release of leucotriene B4 from activated neutrophilsO H Nielsen, I Ahnfelt-Rønne, J Elmgreen
Pharmacology & Toxicology|February 1, 1991
Inhibition of leukotriene biosynthesis and polymorphonuclear leukocyte functions by orally active quinolylmethoxyphenylaminesD Kirstein, M K Thomsen, I Ahnfelt-Rønne
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 18, 2002
Expression of 5-lipoxygenase mRNA is unchanged in the colon of patients with active inflammatory bowel diseaseJ Hendel, I Ahnfelt-Rønne, O H Nielsen
Endocrine|April 27, 2001
Do growth hormone-releasing peptides act as ghrelin secretagogues?I Ahnfelt-Rønne, J Nowak, U B Olsen
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Klinische Wochenschrift|December 15, 1991
Involvement of oxygen-derived free radicals in the pathogenesis of chronic inflammatory bowel diseaseO H Nielsen, I Ahnfelt-Rønne
Agents and Actions|June 1, 1987
The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavengerI Ahnfelt-Rønne, O H Nielsen
Agents and Actions|January 1, 1990
The leukotriene D4/E4 antagonist SR2640: recent results with smooth muscle preparationsD Kirstein, S Rachlin, I Ahnfelt-Rønne
European Journal of Pharmacology|October 11, 1988
A novel leukotriene D4/E4 antagonist, SR2640 (2-[3-(2-quinolylmethoxy)phenylamino]benzoic acid)I Ahnfelt-Rønne, D Kirstein, C Kaergaard-Nielsen
Agents and Actions|January 1, 1989
SR2640 (2-[3-(2-quinolylmethoxy)phenylamino]benzoic acid): a novel leukotriene antagonistI Ahnfelt-Rønne, D Kirstein, C Kaergaard-Nielsen
Agents and Actions|December 1, 1981
Chronic inflammation in adjuvant arthritic rats correlates with enhancement of 12-L-HETE-synthesisI Ahnfelt-Rønne, E Bramm, E Arrigoni-Martelli
Gut|February 1, 1987
Abnormal metabolism of arachidonic acid in chronic inflammatory bowel disease: enhanced release of leucotriene B4 from activated neutrophilsO H Nielsen, I Ahnfelt-Rønne, J Elmgreen
Pharmacology & Toxicology|February 1, 1991
Inhibition of leukotriene biosynthesis and polymorphonuclear leukocyte functions by orally active quinolylmethoxyphenylaminesD Kirstein, M K Thomsen, I Ahnfelt-Rønne
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 18, 2002
Expression of 5-lipoxygenase mRNA is unchanged in the colon of patients with active inflammatory bowel diseaseJ Hendel, I Ahnfelt-Rønne, O H Nielsen
Endocrine|April 27, 2001
Do growth hormone-releasing peptides act as ghrelin secretagogues?I Ahnfelt-Rønne, J Nowak, U B Olsen
Pageof 6